T. Wyss-coray et al., Chronic overproduction of transforming growth factor-beta 1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice, AM J PATH, 156(1), 2000, pp. 139-150
Citations number
69
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Cerebrovascular amyloid deposition and microvascular degeneration are frequ
ently associated with Alzheimer's disease (AD), but the etiology and pathog
enetic role of these abnormalities are unknown, Recently, transforming grow
th factor-beta 1 (TGF-beta 1) was implicated in cerebrovascular amyloid for
mation in transgenic mice with astroglial overproduction of TGF-beta 1 and
in AD. We tested whether TGF-beta 1 overproduction induces AD-like cerebrov
ascular degeneration and analyzed how cerebrovascular abnormalities develop
over time in TGF-beta 1-transgenic mice. In cerebral microvessels from 3-
to 4-month-old TGF-beta 1-transgenic mice, which display a prominent periva
scular astrocytosis, levels of the basement membrane proteins perlecan and
fibronectin were severalfold higher than in vessels from nontransgenic mice
. Consistent with this increase, cortical capillary basement membranes of T
GF-beta 1 mice were significantly thickened, These changes preceded amyloid
deposition, which began at around 6 months of age. In 9- and 18-month-old
TGF-beta 1 mice, various degenerative changes in microvascular cells of the
brain were observed. Endothelial cells were thinner and displayed abnormal
, microvilli-like protrusions as well as occasional condensation of chromat
in, and pericytes occupied smaller areas in capillary profiles than in nont
ransgenic controls. Similar cerebrovascular abnormalities have been reporte
d in AD. Wie conclude that chronic overproduction of TGF-beta 1 triggers an
accumulation of basement mem brane proteins and results in AD-like cerebro
vascular amyloidosis and microvascular degeneration. Closely related proces
ses may induce cerebrovascular pathology in AD.